F1SCHEDULE 2Import tolerance F4fees and standalone MRL application fees
Words in Sch. 2 heading substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 15(2); 2020 c. 1, Sch. 5 para. 1(1)
F3Fees for import tolerances F21
F5Fees chargeable by a Great Britain competent authority for import tolerances are in accordance with the following table.
Item | Category | Fee(£) |
|---|---|---|
F7A1 | Preliminary consideration of an application to determine whether the application can proceed further | 229 |
A2 | Co-ordination of applications | 1,872 |
1 | Full Human health description(1) | 16,224 |
2 | Metabolism and residues evaluation(2) | 6,760 |
3 | Residues evaluation(3) | 2,028 |
Notes
1
F6This category is mainly for active substances not currently approved in respect of the part of Great Britain to which the application relates. In certain cases it may also include active substances still being reviewed if toxicological endpoints have not yet been agreed and accepted in respect of that part of Great Britain.
2
This category is for F8active substances where toxicological endpoints have already been agreed F9and accepted in respect of the part of Great Britain to which the application relates, but the residue definition has only been established for crop groups unrelated to the intended use or imported produce.
3
This category is for F10active substances where relevant toxicological endpoints and residue definition have already been agreed F11and accepted in respect of the part of Great Britain to which the application relates.
F12Fees for multiple import tolerances for the same active substance are calculated on a modular basis with a charge applied for each crop.
F13Fees for standalone MRL applications2
Fees chargeable by a Great Britain competent authority for standalone MRL applications are in accordance with the following table.
Item | Category | Fee (£) |
|---|---|---|
1 | Preliminary consideration of an application to determine whether the application can proceed further | 229 |
2 | Co-ordination of applications | 1,872 |
3 | Full human health description(1) | 16,224 |
4 | Metabolism and residues evaluation(2) | 6,760 |
5 | Residues evaluation(3) | 2,028 |
Notes
1
This category is mainly for active substances not currently approved in respect of the part of Great Britain to which the application relates. In certain cases it may also include active substances still being reviewed if toxicological endpoints have not yet been agreed and accepted in respect of that part of Great Britain.
2
This category is for active substances where toxicological endpoints have already been agreed and accepted in respect of the part of Great Britain to which the application relates but the residue definition has only been established for crop groups unrelated to the intended use.
3
This category is for active substances where relevant toxicological endpoints and residue definition have already been agreed and accepted in respect of the part of Great Britain to which the application relates.
Fees for multiple standalone applications for the same active substance are calculated on a modular basis with a charge applied for each crop or combination of maximum residue levels.
Sch. 2 substituted (6.4.2016) by The Plant Protection Products (Fees and Charges) (Amendment) Regulations 2016 (S.I. 2016/254), regs. 1, 2(3)